Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Jan;35(1):40–51. doi: 10.1038/bjc.1977.2

Effects of varying the interval between courses of methotrexate on its myelotoxic and anti-leukaemic activities.

B Harding, J Culvenor, I C MacLennan
PMCID: PMC2025304  PMID: 831760

Abstract

The toxicity produced by two courses of methotrexate separated by different intervals has been studied in matched groups of rats. The maximum degree of neutropenia reached when courses were separated by 8 days or more was no greater than that seen after a single course of methotrexate. However, when courses of neutropenia following the second course of methotrexate was directly related to the level of depression of bone marrow cell numbers at the time of the second course. Conversely the anti-leukaemic effects of 2 courses of methotrexate, in terms of time of onset of leukaemia and time of death in rats transplanted with a syngeneic T-cell leukaemia, are shown to be similar when courses of methotrexate are separated by between 2 and 12 days. Thus in this system, chemotherapeutic schedules using methotrexate may be designed on the basis of minimal host toxicity without prejudicing anti-leukaemic effects. These results are discussed in relation to toxicity and anti-leukaemic effects observed during UKALL trials of treatment in acute lymphoblastic leukaemia.

Full text

PDF
40

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERLIN N. I., RALL D., MEAD J. A., FREIREICH E. J., VANSCOTT E., HERTZ R., LIPSETT M. B. FOLIC ACID ANTAGONIST. EFFECTS ON THE CELL AND THE PATIENT. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. Ann Intern Med. 1963 Dec;59:931–956. doi: 10.7326/0003-4819-59-6-931. [DOI] [PubMed] [Google Scholar]
  2. Bertino J. R., Hillcoat B. L., Johns D. G. Symposium on immunosuppressive drugs. Folate antagonists: some biochemical and pharmacological considerations. Fed Proc. 1967 May-Jun;26(3):893–897. [PubMed] [Google Scholar]
  3. Borsa J., Whitmore G. F. Cell killing studies on the mode of action of methotrexate on L-cells in vitro. Cancer Res. 1969 Apr;29(4):737–744. [PubMed] [Google Scholar]
  4. Clarkson B. D. Review of recent studies of cellular proliferation in acute leukemia. Natl Cancer Inst Monogr. 1969 May;30:81–120. [PubMed] [Google Scholar]
  5. DELMONTE L., JUKES T. H. Folic acid antagonists in cancer chemotherapy. Pharmacol Rev. 1962 Mar;14:91–135. [PubMed] [Google Scholar]
  6. Dibley M., Dorsch S., Roser B. T cell leukaemia in the rat: the pathophysiology. Pathology. 1975 Jul;7(3):219–235. doi: 10.3109/00313027509094412. [DOI] [PubMed] [Google Scholar]
  7. GOLDIN A., HUMPHREYS S. R., MANTEL N., VENDITTI J. M. Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin. J Natl Cancer Inst. 1956 Aug;17(2):203–212. [PubMed] [Google Scholar]
  8. Hryniuk W. M. Purineless death as a link between growth rate and cytotoxicity by methotrexate. Cancer Res. 1972 Jul;32(7):1506–1511. [PubMed] [Google Scholar]
  9. Krivit W., Brubaker C., Thatcher L. G., Pierce M., Perrin E., Hartmann J. R. Maintenance therapy in acute leukemia of childhood. Comparison of cyclic vs. sequential methods. Cancer. 1968 Mar;21(3):352–356. doi: 10.1002/1097-0142(196803)21:3<352::aid-cncr2820210304>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  10. Morley A., Rickard K., Howard D., Stohlman F., Jr Studies on the regulation of granulopoiesis. IV. Possible humoral regulation. Blood. 1971 Jan;37(1):14–22. [PubMed] [Google Scholar]
  11. Nagao T., Lampkin B. C., Mauer A. M. Maintenance therapy in acute childhood leukemia. J Pediatr. 1970 Jan;76(1):134–137. doi: 10.1016/s0022-3476(70)80146-9. [DOI] [PubMed] [Google Scholar]
  12. SKIPPER H. E., SCHABEL F. M., Jr, BELL M., THOMSON J. R., JOHNSON S. On the curability of experimental neoplasms. I. Amethopterin and mouse leukemias. Cancer Res. 1957 Aug;17(7):717–726. [PubMed] [Google Scholar]
  13. Saunders E. F., Kauder E., Mauer A. M. Sequential therapy of acute leukemia in childhood. J Pediatr. 1967 Apr;70(4):632–635. doi: 10.1016/s0022-3476(67)80053-2. [DOI] [PubMed] [Google Scholar]
  14. Tattersall M. H., Brown B., Frei E., 3rd The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects. Nature. 1975 Jan 17;253(5488):198–200. doi: 10.1038/253198a0. [DOI] [PubMed] [Google Scholar]
  15. VITALE J. J., ZAMCHECK N., DIGIORGIO J., HEGSTED D. M. Effects of aminopterin administration on the respiration and morphology of the gastrointestinal mucosa of rats. J Lab Clin Med. 1954 Apr;43(4):583–594. [PubMed] [Google Scholar]
  16. Vogler W. R., Mingioli E. S., Garwood F. A. The effect of methotrexate on granulocytic stem cells and granulopoiesis. Cancer Res. 1973 Jul;33(7):1628–1633. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES